Details for Patent: 12,290,597
✉ Email this page to a colleague
Which drugs does patent 12,290,597 protect, and when does it expire?
Patent 12,290,597 protects SYMPAZAN and is included in one NDA.
This patent has nine patent family members in six countries.
Summary for Patent: 12,290,597
| Title: | Oral film compositions and dosage forms having precise active dissolution profiles |
| Abstract: | An oral film in an individual unit dose for delivery of one or more actives is disclosed herein, the film having a precisely calculated and controlled active dissolution profile. A wide variety of actives may be used, including, for example, clobazam, diazepam, or riluzole. Also disclosed are methods of treating a variety of diseases and conditions, for example, epilepsy and seizures, by administering the oral film disclosed herein. |
| Inventor(s): | Alexander Mark Schobel, Stephen Wargacki, Vincent J. Buono, Susan Shumard, Christopher James Santee |
| Assignee: | Aquestive Therapeutics Inc |
| Application Number: | US18/091,556 |
|
Patent Claim Types: see list of patent claims | Use; Delivery; |
Drugs Protected by US Patent 12,290,597
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assertio Speclty | SYMPAZAN | clobazam | FILM;ORAL | 210833-001 | Nov 1, 2018 | RX | Yes | No | ⤷ Start Trial | ⤷ Start Trial | Y | METHOD OF TREATING SEIZURES | ⤷ Start Trial | |||
| Assertio Speclty | SYMPAZAN | clobazam | FILM;ORAL | 210833-002 | Nov 1, 2018 | RX | Yes | No | ⤷ Start Trial | ⤷ Start Trial | Y | METHOD OF TREATING SEIZURES | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 12,290,597
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Brazil | 112021004053 | ⤷ Start Trial | |||
| Canada | 3110997 | ⤷ Start Trial | |||
| China | 112955124 | ⤷ Start Trial | |||
| China | 120789028 | ⤷ Start Trial | |||
| European Patent Office | 3846778 | ⤷ Start Trial | |||
| Japan | 2021536466 | ⤷ Start Trial | |||
| Japan | 2025093925 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
